
|Articles|July 12, 2004
Women have new patch for preventing osteoporosis
Clinicians will soon be able to offer postmenopausal women transdermal estrogen therapy that delivers half the dose of the lowest currently available dose of transdermal estrogen. The FDA recently approved estradiol transdermal system (Menostar, Berlex) 14 mcg/d for the prevention of postmenopausal osteoporosis. The product will be available later this summer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Once Weekly Oral HIV Regimen Maintains Suppression Through Week 48
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
4
Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches
5




























